Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 17 - Issue 12 - December, 2005

Feature

Case Report
Bilateral Coronary Ostial Stenoses Post-Bentall Procedure: Management Options in the DES Era
08/01/2008
Matthew I. Worthley, MBBS, PhD, FRACP, John Burgess, MD, FRCS(C), Mouheiddin Traboulsi, MD, FRCP(C)
Matthew I. Worthley, MBBS, PhD, FRACP...
The Bentall procedure for aortic root and valve replacement with coronary reimplantation was initially described in 1968.1 This procedure is considered the “gold standard” for treatment of combined valve and ascending aortic pathology. The...
The Bentall procedure for aortic root and valve replacement with coronary reimplantation was initially described in 1968.1 This procedure is considered the “gold standard” for treatment of combined valve and ascending aortic pathology. The...
The Bentall procedure for aortic...
08/01/2008
Journal of Invasive Cardiology
Intravascular Thermographic Assessment in Human Coronary Atherosclerotic Plaques by a Novel Flow-Occluding Sensing Catheter: A S
08/01/2008
Jorge A. Belardi, MD, PhD, Mariano Albertal, MD, PhD, Fernando A. Cura, MD, Oscar Mendiz, MD, Pablo Perez Balino, MD, Lucio T. Padilla, MD, *Michael Lauer, MD, *Joe Korotko, PhD, *William O’Neill, MD
Jorge A. Belardi, MD, PhD, Mariano Al...
Previous studies support the concept that atherosclerosis is an inflammatory disease.1,2 Inflammation plays an important role not only in the development, but also in the acute complications of atherosclerotic plaques.3 The detection of...
Previous studies support the concept that atherosclerosis is an inflammatory disease.1,2 Inflammation plays an important role not only in the development, but also in the acute complications of atherosclerotic plaques.3 The detection of...
Previous studies support the...
08/01/2008
Journal of Invasive Cardiology
Safety and Efficacy of the Percutaneous Radial Artery Approach
for Coronary Angiography and Angioplasty in the Elderly
08/01/2008
Gionata Molinari, MD, Ilaria Nicoletti, MD, Marialuisa De Benedictis, MD, Clotilde Terraneo, MD, Giorgio Morando, MD, Marco Turri, MD, Maurizio Anselmi, MD, Piero Zardini, MD Giuliana Menegatti, MD, Corrado Vassanelli, MD
Gionata Molinari, MD, Ilaria Nicolett...
Percutaneous coronary catheterization and revascularization are commonly performed all over the world. Among various access sites for coronary interventions, most cardiologists favor the femoral approach, while the procedure via the radial...
Percutaneous coronary catheterization and revascularization are commonly performed all over the world. Among various access sites for coronary interventions, most cardiologists favor the femoral approach, while the procedure via the radial...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Coronary Artery Stenting in Patients with Severe Left Ventricular Dysfunction
08/01/2008
1Farhan Aslam, MD and 2James C. Blankenship, MD, FACC
1Farhan Aslam, MD and 2James C. Blank...
Percutaneous transluminal coronary angioplasty (PTCA) may be an effective treatment in selected patients with left ventricular dysfunction, but acute and long-term mortality rates are higher than in patients with normal left ventricular...
Percutaneous transluminal coronary angioplasty (PTCA) may be an effective treatment in selected patients with left ventricular dysfunction, but acute and long-term mortality rates are higher than in patients with normal left ventricular...
Percutaneous transluminal...
08/01/2008
Journal of Invasive Cardiology
Drug-Eluting Stents versus Repeat Vascular Brachytherapy for Patients with Recurrent In-Stent Restenosis after Failed Intracoron
08/01/2008
William W. Chu, MD, PhD, Rebecca Torguson, BS, Augusto D. Pichard, MD, Lowell F. Satler, MD, Rosanna Chan, PhD, Michael Porrazzo, MD, Kenneth M. Kent, MD, William O. Suddath, MD, Ron Waksman, MD
William W. Chu, MD, PhD, Rebecca Torg...
Intracoronary radiation therapy (IRT) for in-stent restenosis (ISR) in native coronary arteries and saphenous vein grafts (SVG) has substantially reduced the rate of recurrent restenosis compared with conventional percutaneous coronary...
Intracoronary radiation therapy (IRT) for in-stent restenosis (ISR) in native coronary arteries and saphenous vein grafts (SVG) has substantially reduced the rate of recurrent restenosis compared with conventional percutaneous coronary...
Intracoronary radiation therapy...
08/01/2008
Journal of Invasive Cardiology
The Physics of Guiding Catheters for the Left Coronary Artery
in Transfemoral and Transradial Interventions
08/01/2008
Yuji Ikari, MD, PhD, Masakazu Nagaoka, MD, Jae-Young Kim, MD, Yoshihiro Morino, MD, Teruhisa Tanabe, MD, PhD
Yuji Ikari, MD, PhD, Masakazu Nagaoka...
Although the backup force of a guiding catheter is important for successful percutaneous coronary intervention (PCI), no theory has been proposed thus far regarding the factors involved in its generation. Thus far, our understanding stems...
Although the backup force of a guiding catheter is important for successful percutaneous coronary intervention (PCI), no theory has been proposed thus far regarding the factors involved in its generation. Thus far, our understanding stems...
Although the backup force of a...
08/01/2008
Journal of Invasive Cardiology
Risk of Local Adverse Events following Cardiac Catheterization
by Hemostasis Device Use — Phase II
08/01/2008
aDale R. Tavris, MD, MPH, bSyamal Dey, MS, PhD, aBeverly Albrecht-Gallauresi, RN, MPH, cRalph G. Brindis, MD, MPH, FACC, dRichard Shaw, PhD, FACC, eWilliamWeintraub, MD, FACC, bKristi Mitchel, MPH *This study was funded by the Office of Women's Health of the Food and Drug Administration (FDA). The opinions or assertions presented herein are the private views of the authors and are not to be construed as conveying either an official endorsement or criticism by the U.S. Food and Drug Administration.
aDale R. Tavris, MD, MPH, bSyamal Dey...
Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to...
Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to...
Reports to the Center for...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
The Guiding Catheter: The Most Underrated Asset to Coronary Angioplasty
08/01/2008
Bernhard Meier, MD
Bernhard Meier, MD
It was the guiding catheter that prevented the successful clinical launch of percutaneous transluminal coronary angioplasty on March 22, 1976. The patient was afflicted with generalized atherosclerosis. His aorta was completely occluded....
It was the guiding catheter that prevented the successful clinical launch of percutaneous transluminal coronary angioplasty on March 22, 1976. The patient was afflicted with generalized atherosclerosis. His aorta was completely occluded....
It was the guiding catheter that...
08/01/2008
Journal of Invasive Cardiology
Commentary
Safety of the Radial Artery Approach in the Elderly
08/01/2008
Shahid Aziz, MBChB, BSc, MRCP and David R. Ramsdale MD, FRCP
Shahid Aziz, MBChB, BSc, MRCP and Dav...
Since the first description of transradial coronary stent implantation in 1993,1 there has been a rapid increase in the number of coronary diagnostic and interventional procedures using this approach. The radial artery (RA) technique has...
Since the first description of transradial coronary stent implantation in 1993,1 there has been a rapid increase in the number of coronary diagnostic and interventional procedures using this approach. The radial artery (RA) technique has...
Since the first description of...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

December 2005 Volume 17 Issue 12

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement